We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Lipocine Inc (LPCN) - Financial and Strategic SWOT Analysis Review

Published: March 2019
Pages: 25
Code: 41D1E395A730097C1E9D31B55CB6BBFF
Format: PDF
Publisher GlobalData
From Add to basket
$ 300.00
Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone product candidate and LPCN 1021 is an oral testosterone replacement therapy with positive topline. Lipocine offers LPCN 1107, an oral hydroxyprogesterone caproate product for prevention of preterm birth. The company develops patented technology based on lipidic compositions that form optimal dispersed phase in the gastrointestinal environment for improved absorption of the insoluble drug. Its Lip'ral is a technology based on lipidic compositions that form optimal dispersed phase in the gastrointestinal environment. Lipocine is headquartered in Salt Lake City, Utah, the US.
Lipocine Inc Key Recent Developments
Mar 06,2019: Lipocine announces financial and operational results for the year ended December 31, 2018
Jan 14,2019: USPTO grants priority motion to Lipocine and enters judgment against Clarus
Nov 07,2018: Lipocine announces financial and operational results for the three and nine months ended September 30, 2018
Aug 07,2018: Lipocine announces financial and operational results for the second quarter and six months ended June 30, 2018
May 07,2018: Lipocine Reported Financial and Operational Results for the First Quarter Ended March 31, 2018
This comprehensive SWOT profile of Lipocine Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Lipocine Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • Table of Contents
  • Section 1 - About the Company
  • Lipocine Inc - Key Information
  • Lipocine Inc - Overview
  • Lipocine Inc - Key Employees
  • Lipocine Inc - Key Employee Biographies
  • Lipocine Inc - Key Operational Heads
  • Lipocine Inc - Major Products and Services
  • Lipocine Inc - History
  • Lipocine Inc - Company Statement
  • Lipocine Inc - Locations And Subsidiaries
  • Lipocine Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • Lipocine Inc - Business Description
  • Lipocine Inc - Corporate Strategy
  • Lipocine Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Lipocine Inc - Strengths
  • Lipocine Inc - Weaknesses
  • Lipocine Inc - Opportunities
  • Lipocine Inc - Threats
  • Lipocine Inc - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • Lipocine Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company
  • List of Tables
  • Lipocine Inc, Key Information
  • Lipocine Inc, Key Ratios
  • Lipocine Inc, Share Data
  • Lipocine Inc, Major Products and Services
  • Lipocine Inc, History
  • Lipocine Inc, Key Employees
  • Lipocine Inc, Key Employee Biographies
  • Lipocine Inc, Key Operational Heads
  • Lipocine Inc, Other Locations
  • Lipocine Inc, Subsidiaries
  • Lipocine Inc, Key Manufacturing facilities
  • Lipocine Inc, Key Competitors
  • Lipocine Inc, SWOT Analysis
  • Lipocine Inc, Ratios based on current share price
  • Lipocine Inc, Annual Ratios
  • Lipocine Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Lipocine Inc, Performance Chart
  • Lipocine Inc, Ratio Charts